IL6 and COVID-19: Via the TLR9 pathways, a plethora of inflammatory mediators and cell types can be triggered such as interleukin-6 (IL-6) and tumor necrosis factor (TNF)-α in severely ill patients with COVID-19 (Bezemer and Garssen, 2021; Rubin et al., 2021).